EP
Epsilon Healthcare Limited
EPN.AX · ASX
$0.03 +0.00% (+$0.00)
1M +4.00%
Market Cap $10.1M
P/E Ratio -
Div. Yield -
ROE 201.01%
Analiza
Raport AI o biznesie, finansach, wycenie, sentymencie, wiadomościach i ryzykach - napisany w kilka minut.
Piotroski F-Score Strong
7/9Valuation
80 /100
Cheap P/B 3.38x
P/S 1.08x
EV/FFO N/A
Growth
51 /100
Stable Book val. growth 31.43%
Rev. growth 9.72%
FCF growth N/A
Profitability
8 /100
Weak Op. margin 23.61%
Gross margin 23.99%
FCF margin 35.09%
Quality
7 /100
Poor ROA 11.48%
ROIC 10.90%
Asset turnover 0.53x
Debt
11 /100
High Int. coverage -1.77x
Debt/Equity 4.74x
Current ratio 1.14x
Stability
26 /100
Unstable EPS volatility 122.78%
Beta 0.75x
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o EPN.AX
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Peter Giannopoulos
Employees
14
Headquarters
Southport